Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
IgG4-Related Disease
Questions discussed in this category
How would you treat a perineural IgG4-RD with persistent paresthesia?
Would you continue corticosteroid therapy even with a normalized serum IgG4 concentration?
1 Answer available
Is there utility in monitoring IgE levels in patients with IgG4-RD?
1 Answer available
How would you manage a patient with highly active ankylosing spondylitis, iritis and Crohn’s, controlled with weekly adalimumab with co-morbid IgG4RD and intolerance of azathioprine due to elevated LFTs?
IgG4 manifestations include autoimmune pancreatitis and periaortic soft tissue mass.
2 Answers available
What is your approach to a patient with IgG4RD with past pulmonary involvement (biopsy proven) managed with steroids alone, now with new hematuria/proteinuria, but stable renal function?
Would you obtain renal biopsy first or treat with additional immunosuppression for suspected renal involvement related to IgG4?
4 Answers available
How would you manage autoimmune pancreatitis in a patient after Whipple's procedure?
1 Answer available
What is your treatment algorithm for management of retroperitoneal fibrosis that does not respond to high-dose glucocorticoids?
1 Answer available
When would you consider rituximab as induction therapy in IgG4-related disease?
4 Answers available
Would you intensify therapy in IgG4 related disease based solely on a persistently significantly elevated IgG4 level when all disease manifestations and inflammatory markers have normalized?
1 Answer available
How do you approach a patient with IgG4-related disease who has failed rituximab and mycophenolate and continues to rely on high-dose steroids?
The case I am considering involves a patient with biopsy-proven fibrosing dacryoadenitis.
1 Answer available
21090
18938
18906
17156
17960
14098
12325
12203
9879
Papers discussed in this category
Annals of the rheumatic diseases, 2015-06
Rituximab for IgG4-related disease: a prospective, open-label trial.
Neth J Med,
The treatment outcomes in IgG4-related disease.
Medicine (Baltimore),
Therapeutic approach to IgG4-related disease: A systematic review.
Ann Rheum Dis, 2020 Jan
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Related Topics
Rheumatology
Internal Medicine
Gastroenterology
General Rheumatology
Pancreatic Disorders
General Gastroenterology
Nephrology
Non-malignant Disease
Radiation Oncology
General Hepatology